Discovery of prostate cancer biomarkers by microarray gene expression profiling.
about
Biomarkers of postoperative delirium and cognitive dysfunctionMultiscale integration of -omic, imaging, and clinical data in biomedical informatics.How to get the most from microarray data: advice from reverse genomics.siRNA knockdown of ribosomal protein gene RPL19 abrogates the aggressive phenotype of human prostate cancer.PINCAGE: probabilistic integration of cancer genomics data for perturbed gene identification and sample classification.Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population.Biomarkers for colorectal cancerDifferentially expressed androgen-regulated genes in androgen-sensitive tissues reveal potential biomarkers of early prostate cancerEffect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryGenomic "Dark Matter" in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers.Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.UVB suppresses PTEN expression by upregulating miR-141 in HaCaT cells.Expression profiling of cervical cancers in Indian women at different stages to identify gene signatures during progression of the disease.Multiplexed detection of molecular biomarkers with phase-change nanoparticlesTen questions about systems biology.Fundamental role of microRNAs in androgen-dependent male reproductive biology and prostate cancerogenesis.Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers.Prognostic prediction following radical prostatectomy for prostate cancer using conventional as well as molecular biological approaches.Translating metastasis-related biomarkers to the clinic--progress and pitfalls.Exosomal miRNAs as Biomarkers for Prostate Cancer.Nutraceuticals for prostate cancer chemoprevention: from molecular mechanisms to clinical application.Clinically relevant genetic characterization of prostate tumors: how close are we to the goal?Biobanking of derivatives from radical retropubic and robot-assisted laparoscopic prostatectomy tissues as part of the prostate cancer biorepository network.MiR-141 Inhibits Gastric Cancer Proliferation by Interacting with Long Noncoding RNA MEG3 and Down-Regulating E2F3 Expression.Down-regulation of calcium/calmodulin-dependent protein kinase kinase 2 by androgen deprivation induces castration-resistant prostate cancer.Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.DNA methylation status is more reliable than gene expression at detecting cancer in prostate biopsy.Insights into cancer mechanisms from genomic research on urological cancers.Translationally controlled tumor protein in prostatic adenocarcinoma: correlation with tumor grading and treatment-related changes.Genetic testing for metastasis: potential for improved cancer treatment.
P2860
Q26830796-E13FED2F-FC74-4ED6-BAD1-F57CC852CA22Q30581136-2B3A0028-3684-49F9-BED6-4D604ACE593BQ30783271-310DAD69-2933-46AA-974A-BCC8DAF16954Q31028906-CCA88AB5-0B92-493D-9B47-E45603C1FF23Q31035683-3F77F66D-A4E7-4655-A29B-6C45E744013EQ33898869-6E4C08A6-A1B9-4356-B821-D555C08F01A5Q34205596-142A54DB-D5ED-4343-BE3E-9942C66D1C6FQ34805223-A5E4A3FE-D60C-4C54-B42E-D67C6F95D774Q35211723-ED093C86-9B8E-4122-9845-D7975CF0EFC3Q35771477-B564EAC9-7D84-47B5-BAB0-D0D8C0B6B194Q36021088-96E4C711-138D-4F8A-9946-0D176CFBA090Q36681991-FA009138-A3C6-4D49-92B8-EBB6C8C28C98Q37481159-729A3A52-B9E5-4842-B5B0-60C2F53132CFQ37702599-9B5F46F6-84AC-4879-9CCA-88C02283D88DQ37827645-13EC39E6-B6B1-438B-8CBD-3202E9E5B09FQ38005767-BC8E4F8D-602C-4414-8D12-AF679F7E33CCQ38042634-E1F181C1-0749-4813-854E-AEDDF2DA0D1CQ38047420-9D4220A5-CFFC-42E6-99FA-56CB0820DE23Q38079125-564F736D-1BCE-44FD-BE37-563EC270DF8EQ38091950-E1BB1020-EE59-4929-A12F-FFD214F656A5Q38139567-A3C19822-95BC-4F8D-ACC2-CDC728544817Q38356863-3697FD0F-7373-4611-8B68-A985AACBCC75Q38404130-8113182B-87B8-4A96-BFCB-96C532EC1C60Q38847315-AA3FC2CB-A6EE-4DD8-BD50-54DDBE2A7309Q39355407-AEF6ADCB-4191-41A0-8647-74AAD3EAF86AQ41126812-B9BEFB5F-D9EF-45D3-82D5-03B0365CF7A4Q42676794-6979913D-E774-4E16-B367-457C739E43AFQ42731544-912FE554-3684-4760-9EC0-925EF647892DQ43125303-976784E6-0A68-4C65-AFC9-00123370921CQ51701169-FC910A01-BBDD-49FE-BA05-D01B075FECCB
P2860
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@en
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@nl
type
label
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@en
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@nl
prefLabel
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@en
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@nl
P2860
P356
P1476
Discovery of prostate cancer biomarkers by microarray gene expression profiling.
@en
P2860
P356
10.1586/ERM.09.74
P577
2010-01-01T00:00:00Z